Benzinga | Jan 20, 2022 09:17AM EST

Laidlaw & Co. Initiates Coverage On Cingulate with Buy Rating, Announces Price Target of $8.5

Laidlaw & Co. analyst Yale Jen initiates coverage on Cingulate (NASDAQ:CING) with a Buy rating and announces Price Target of $8.5.